...Good morning. This is Arthur Sands, President and Chief Executive Officer of Nurix Therapeutics. I would like to welcome you to Nurix's 2025 Annual Meeting of Stockholders. It is 9:00 AM Pacific Time on Monday, May 19, 2025, and this meeting is officially called to order. The agenda for today's meeting is presented on this slide. I will first introduce our independent auditors and our Inspector of Elections, and then I will review the legal requirements for conducting business at this meeting. The polls will then be open for voting, and I will introduce the items of business at this meeting. During voting, I will provide key highlights of the company's achievements and progress in the past year. After my presentation, the polls will be closed, and I will provide the preliminary voting results. We will conclude with a brief question-and-answer session, where stockholders may submit a question by typing it in the Ask a Question section at the bottom left of your screen. We will answer questions...
